Literature DB >> 9024271

UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.

A Widjaja1, I M Stratton, R Horn, R R Holman, R Turner, G Brabant.   

Abstract

We measured plasma leptin and insulin concentrations across a spectrum of obesity in 829 white Caucasian, 154 Afro-Caribbean, and 204 Asian type 2 diabetic subjects. Although the leptin concentrations covered a large range, there were no subgroups of diabetic subjects with very high or low leptin levels that would suggest mutations in the leptin gene or leptin receptor gene comparable to the obese diabetic ob/ob and db/db mice models respectively. In all three ethnic groups, leptin concentrations correlated with body mass index (BMI) in a similar manner to nondiabetic patients and were higher in females than males after adjustment for BMI, with no difference between ethnic groups. In a multivariate regression analysis, plasma leptin was associated with gender and BMI, (both P < 1 x 10(-17)) and with fasting plasma insulin concentrations (P = 5 x 10(-9)). Subjects treated with insulin had both raised insulin and leptin concentrations. When matched for different therapies, gender, and BMI, diabetic subjects with high leptin levels also had high insulin levels (P < 0.0009). High leptin concentrations may in part be influenced by hyperinsulinemia or impaired insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024271     DOI: 10.1210/jcem.82.2.3744

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Isothiocyanate-rich Moringa oleifera extract reduces weight gain, insulin resistance, and hepatic gluconeogenesis in mice.

Authors:  Carrie Waterman; Patricio Rojas-Silva; Tugba Boyunegmez Tumer; Peter Kuhn; Allison J Richard; Shawna Wicks; Jacqueline M Stephens; Zhong Wang; Randy Mynatt; William Cefalu; Ilya Raskin
Journal:  Mol Nutr Food Res       Date:  2015-04-27       Impact factor: 5.914

2.  Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes Mellitus.

Authors:  Martina Montagnana; Cristiano Fava; Giovanni Targher; Massimo Franchini; Elisa Danese; Sara Bonafini; Angela De Cata; Gian Luca Salvagno; Orazio Ruzzenente; Gian Cesare Guidi; Giuseppe Lippi
Journal:  J Clin Lab Anal       Date:  2016-07-29       Impact factor: 2.352

3.  Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India.

Authors:  A Rosalind Marita; Joy A Sarkar; Sujata Rane
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

Review 4.  Current concepts in the pharmacological management of obesity.

Authors:  P J Carek; L M Dickerson
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 5.  Adiponectin and leptin: potential tools in the differential diagnosis of pediatric diabetes?

Authors:  Milagros Gloria Huerta
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

6.  Leptin levels in patients with type 1 diabetes receiving intensive insulin therapy compared with those in patients receiving conventional insulin therapy.

Authors:  S T Azar; P A Zalloua; M S Zantout; C H Shahine; I Salti
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

7.  Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample.

Authors:  Erik Ingelsson; Martin G Larson; Xiaoyan Yin; Thomas J Wang; James B Meigs; Izabella Lipinska; Emelia J Benjamin; John F Keaney; Ramachandran S Vasan
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

8.  Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes.

Authors:  A-M Aas; I Seljeflot; P A Torjesen; L M Diep; P M Thorsby; K I Birkeland
Journal:  Diabetologia       Date:  2006-03-23       Impact factor: 10.122

9.  Clinical and biochemical effects of a 3-week program of diet combined with spa therapy in obese and diabetic patients: a pilot open study.

Authors:  Antonella Fioravanti; Przemysław Adamczyk; Nicola Antonio Pascarelli; Chiara Giannitti; Renato Urso; Michał Tołodziecki; Irena Ponikowska
Journal:  Int J Biometeorol       Date:  2014-09-07       Impact factor: 3.787

10.  Lower leptin levels in young non-obese male smokers than non-smokers.

Authors:  Bayram Koc; Fatih Bulucu; Nuri Karadurmus; Mustafa Sahin
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.